A detailed history of Rockwood Wealth Management, LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Rockwood Wealth Management, LLC holds 107,329 shares of FHTX stock, worth $843,605. This represents 0.11% of its overall portfolio holdings.

Number of Shares
107,329
Previous 107,329 -0.0%
Holding current value
$843,605
Previous $617 Million 61.91%
% of portfolio
0.11%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$2.82 - $7.94 $302,721 - $852,343
-107,348 Reduced 50.0%
107,329 $720 Million
Q1 2023

Jul 20, 2023

SELL
$4.66 - $8.99 $284,819 - $549,468
-61,120 Reduced 22.16%
214,677 $1.33 Billion
Q4 2022

Jul 20, 2023

BUY
$5.44 - $9.46 $825,612 - $1.44 Million
151,767 Added 122.36%
275,797 $1.76 Billion
Q3 2022

Jul 20, 2023

BUY
$7.52 - $18.01 $932,705 - $2.23 Million
124,030 New
124,030 $1.06 Billion

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $327M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Rockwood Wealth Management, LLC Portfolio

Follow Rockwood Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockwood Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rockwood Wealth Management, LLC with notifications on news.